老虎證券
Invest
Pricing
Rewards
Support
Learn
About
Quotes
TigerAI
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
Emmaus生命科學
0.0154
+0.0015
11.06%
成交量:
3.09萬
成交額:
460.07
市值:
108.37萬
市盈率:
-0.14
高:
0.0155
開:
0.0146
低:
0.0146
收:
0.0139
52周最高:
0.0470
52周最低:
0.0080
股本:
7,019.83萬
流通股本:
3,598.82萬
量比:
1.08
換手率:
0.09%
股息:
- -
股息率:
- -
每股收益(TTM):
-0.1141
每股收益(LYR):
-0.0703
淨資產收益率:
-13.36%
總資產收益率:
-1.89%
市淨率:
-0.02
市盈率(LYR):
-0.22
資料載入中...
總覽
公司
新聞資訊
公告
概念
沒有相關數據
資金流向
資金流入:
資金流出:
實時
日
周
月
季度
年
新聞資訊
Emmaus生命科學授予Nit公司Endari在美國及加拿大的獨家營銷權
美股速递
·
2025/12/31
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎國際,美股交易,港股交易,交易美股,股票信息,股價,美股行情,美股打新,港股打新,IPO打新,購買美股,全球投資","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/EMMA"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"EMMA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"EMMA\",,,,,undefined,":{"symbol":"EMMA","market":"US","secType":"STK","nameCN":"Emmaus生命科學","latestPrice":0.015437,"timestamp":1770670800000,"preClose":0.0139,"halted":0,"volume":30850,"delay":15,"changeRate":0.11057553956834534,"floatShares":35988185,"shares":70198300,"eps":-0.114131,"marketStatus":"已收盤","change":0.001537,"latestTime":"02-09 16:00:00 EST 延時","open":0.0146,"high":0.0155,"low":0.0146,"amount":460.06875,"amplitude":0.064748,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.114131,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1770714000000},"marketStatusCode":5,"adr":0,"exchange":"OTCQB","adjPreClose":0.0139,"volumeRatio":1.075978},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"EMMA\",,,,,undefined,":{"symbol":"EMMA","floatShares":35988185,"roa":"-1.89%","roe":"-13.36%","lyrEps":-0.070294,"volumeRatio":1.075978,"shares":70198300,"dividePrice":0,"high":0.0155,"amplitude":0.064748,"preClose":0.0139,"low":0.0146,"week52Low":0.008,"pbRate":"-0.02","psRate":"0.09","week52High":0.047,"institutionHeld":0,"latestPrice":0.015437,"eps":-0.114131,"divideRate":0,"volume":30850,"delay":15,"ttmEps":-0.114131,"open":0.0146,"prevYearClose":0.013,"prevWeekClose":0.0139,"prevMonthClose":0.0139,"prevQuarterClose":0.013,"fiveDayClose":0.0139,"twentyDayClose":0.013,"sixtyDayClose":0.0113},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/EMMA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-11-19","symbol":"EMMA","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1731992400000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2022-11-14","symbol":"EMMA","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1668402000000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2022-08-15","symbol":"EMMA","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1660536000000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2019-11-12","symbol":"EMMA","fiscalQuarterEnding":null,"expectedEps":-1.32,"name":null,"time":"盤前","type":"earning","dateTimestamp":1573534800000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2019-08-12","symbol":"EMMA","fiscalQuarterEnding":"2019/06","expectedEps":-1.56,"name":null,"time":"","type":"earning","dateTimestamp":1565582400000,"reportTimeType":"","actualEps":-1.2}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"EMMA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"EMMA\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"EMMA\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1117179498","title":"Emmaus生命科學授予Nit公司Endari在美國及加拿大的獨家營銷權","url":"https://stock-news.laohu8.com/highlight/detail?id=1117179498","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1117179498?lang=zh_tw&edition=fundamental","pubTime":"2025-12-31 05:33","pubTimestamp":1767130391,"startTime":"0","endTime":"0","summary":"Emmaus生命科学公司已正式签署协议,将其创新药物Endari在美国与加拿大地区的独家市场推广、销售及分销权利授予Nit公司。\n此次授权合作将显著拓展Endari在北美市场的可及性,为当地患者提供这一重要治疗选择。双方将协同推进该药物的商业化进程,深化在罕见病治疗领域的战略布局。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EMMA","BK4007"],"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":1,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/EMMA\",params:#limit:6,delay:false,,,undefined,":[]}}